Last updated on May 2020

A Study to Evaluate SAGE-217 in Adult Subjects With Major Depressive Disorder

Brief description of study

This is a phase 3, open-label, 1-year study of the safety, tolerability, and need for re-treatment with SAGE-217 in adult subjects with major depressive disorder

Clinical Study Identifier: NCT03864614

Find a site near you

Start Over

Sage Investigational Site

Bradenton, FL United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.